FTO and neoplasm: We found that FTO-specific pharmacologic inhibitors FB23-2 and MA resulted in a similar of both apoptosis induction and proliferation inhibition in IDH1wt gliomaspheres (Fig. 2H–L), suggesting that FTO may be a critical target of D-2-HG whose inhibition can reduce tumor growth (14, 25).